These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
774 related articles for article (PubMed ID: 17690557)
1. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma. Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557 [TBL] [Abstract][Full Text] [Related]
2. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852 [TBL] [Abstract][Full Text] [Related]
3. [A clinical analysis of 153 uterine sarcomas]. Bai P; Sun J; Chao H Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison. Kim HS; Han KH; Chung HH; Kim JW; Park NH; Song YS; Kang SB Eur J Surg Oncol; 2010 Jul; 36(7):691-8. PubMed ID: 20570475 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas. Sorbe B; Johansson B Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339 [TBL] [Abstract][Full Text] [Related]
12. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Abeler VM; Røyne O; Thoresen S; Danielsen HE; Nesland JM; Kristensen GB Histopathology; 2009 Feb; 54(3):355-64. PubMed ID: 19236512 [TBL] [Abstract][Full Text] [Related]
13. Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival? Garg G; Shah JP; Toy EP; Bryant CS; Kumar S; Morris RT Gynecol Oncol; 2010 Jul; 118(1):8-13. PubMed ID: 20447684 [TBL] [Abstract][Full Text] [Related]
14. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan. Sagae S; Yamashita K; Ishioka S; Nishioka Y; Terasawa K; Mori M; Yamashiro K; Kanemoto T; Kudo R Oncology; 2004; 67(1):33-9. PubMed ID: 15459493 [TBL] [Abstract][Full Text] [Related]
15. Ovarian preservation in stage I low-grade endometrial stromal sarcomas. Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256 [TBL] [Abstract][Full Text] [Related]
16. A multi-institutional review of outcomes of endometrial stromal sarcoma. Leath CA; Huh WK; Hyde J; Cohn DE; Resnick KE; Taylor NP; Powell MA; Mutch DG; Bradley WH; Geller MA; Argenta PA; Gold MA Gynecol Oncol; 2007 Jun; 105(3):630-4. PubMed ID: 17320937 [TBL] [Abstract][Full Text] [Related]
17. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Reed NS; Mangioni C; Malmström H; Scarfone G; Poveda A; Pecorelli S; Tateo S; Franchi M; Jobsen JJ; Coens C; Teodorovic I; Vergote I; Vermorken JB; Eur J Cancer; 2008 Apr; 44(6):808-18. PubMed ID: 18378136 [TBL] [Abstract][Full Text] [Related]